Soo RA, Vervita K, Fruh M, Cho BC, et al. A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial. Lung Cancer 2025;202:108454.
PMID: 40023017